Role and Responsibilities of the CEO

The University of Toulouse is calling for applications for the crucial strategic position of chief executive officer of the UCI.

The CEO will run the UCI, including the hospital and the Cancer Research Center of Toulouse. He or she will bring vision and direct main orientations for research and care. The CEO will define the medical and scientific project, working in conjunction with key stakeholders and the team. He or she will then be responsible for implementing the project, considering its relevance on works of research, and overseeing issues such as translational research, therapeutic protocols, technological platforms, innovation transfer and international partnerships.

Main responsibilities include:

• Drawing up medical and scientific programs, budgets and reports;
• Establishing and developing new clinical and research labs at the UCI (the hospital and the CRCT);
• Further promoting the UCI on an international level as one of the world’s most renowned cancer centers;
• Advancing the industrial development of UCI findings, together with Oncopole partners (pharmaceutical companies, the Centre Pierre Potier/ITAV, etc.); and
• Developing strategic partnerships with industrial groups as well as innovative small to mid-sized enterprises with the goal of stimulating technology transfer.

The CEO will chair a board that will include the secretary general, the research director and the hospital director.

The CEO of the UCI must be a MD and PhD and have a successful track record managing a hospital, and/or a translational research lab, and/or a national health or research organization. International health and science management, fundraising and diplomatic skills are also highly valued for this position.

The CEO will start no later than January 1, 2013. This is a 5-year position with an internationally competitive salary, which will be subject after the term to performance-based annual increases.

Candidates should email their curriculum vitae + letter of application + list of publications + letters of recommendation to: The President of the University of Toulouse 3, Pr. Gilles FOURTANIER (iuc.recrutement@univ-tlse3.fr).

All applications will be considered by the search committee. Selected applicants will first meet with our executive search agency, then with the nominating committee, chaired by John Mendelsohn. The short-list will be submitted to the French Ministry of Health and the Ministry of Higher Education and Research.

For more information, contact our search firm, Your Voice, desk@your-voice.fr.

http://www.oncopole-toulouse.com